A recent study evaluated the effects of colesevelam as antidiabetes monotherapy in adults with T2DM who had inadequate glycemic control ( hemoglobin A1C 7.5 to 9.5 % ) with diet and exercise alone ; we report here the effects on lipoprotein particle subclasses .